Tag Archives: Nutraceuticals

LEHVOSS Group forms JV with Engredo in Denmark

Hamburg based Distributor strengthens Nutrition & Pharma Activities in the Nordic Region

Privately owned distributor of speciality chemicals and ingredients Lehmann&Voss&Co. [LEHVOSS Group] (Hamburg, Germany) has recently entered into a Joint Venture with Engredo ApS (Vejle, Denmark) in order to expand and strengthen its business activities regarding Ingredients and Minerals for the Nutritional Supplements, Pharmaceuticals and Feed sectors in the Nordic region.

The new JV allows for the synergistic combination of product portfolios as well as regulatory and sourcing expertise, LEHVOSS said in a statement. No financial details were disclosed on the transaction.


Source: LEHVOSS press release


HGE – DCG / 04.06.2021



IMCD has acquired VitaQualy in Brazil

Consolidation continues in the Brazilian Ingredients Distribution Market

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands) announced earlier in the week that it has acquired 100% of the outstanding shares of VitaQualy Comércio de Ingredientes LTDA [“VitaQualy”] (São Paulo, SP – Brazil), a specialty ingredients distributor serving the Food & Nutrition, Pharmaceuticals and Nutraceuticals markets.

In 2019, VitaQualy generated revenues of BRL 26 mn (ca. EUR 7.2 mn) with 8 employees. The company will be fully integrated into IMCD’s organisation in 2021, the statement said. 

No financial details were disclosed on this transaction.

Source: IMCD press release

HGE – DCG / 21.08.2020

IMCD to acquire DCS Pharma AG in Switzerland

Existing IMCD Excipients Offering to be augmented with strong API Presence of newly acquired Entity

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands)  announced that it has signed an agreement to acquire 100% of the outstanding shares of DCS Pharma AG (Basel, BS – Switzerland) in a two-step process for an undisclosed sum. 90% of the shares will be acquired at the closing of the transaction, the remaining 10% ca. two years later, effective 31. December 2021.

DCS Pharma, a distributor of Active Pharmaceutical Ingredients (“APIs”), traces its roots back to two Swiss distributors of products  for the pharma and the nutraceutical industry, the Pharma business of Dolder AG and ChemSwiss AG, which were merged in 2016. Today the company operates with a total of 64 employees in seven countries besides Switzerland, including Spain, Italy, Germany, Mexico and China. In 2018, it generated sales of CHF 68 mn, IMCD said in a statement.

IMCD further said it expects formulation and marketing synergies between the newly acquired API activities and its existing business, which is mainly focused on Excipients. Customers of DCS Pharma should benefit from a significantly increased network, according to its CEO Beat Berger.

No financial details were disclosed on the transaction, which is subject to fulfilling customary closing conditions.

Source: IMCD press release

HGE – DCG / 01.11.2019